Aiolos Bio
Drug Discovery
Aiolos Bio valuation and funding history | Last updated: October 24, 2023 | 1 funding rounds
Current Valuation
N/A
As of October 24, 2023
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series A)
$245.0M
Last Funding
Oct 2023
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| October 24, 2023 | Early Stage VC (Series A) | $245.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Aiolos Bio is currently valued at N/A as of October 24, 2023.
What is Aiolos Bio Worth in 2026?
Aiolos Bio is a leading private company in the Drug Discovery sector. Track Aiolos Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Aiolos Bio Valuation is Determined
Private company valuations like Aiolos Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.